Services

Diagnosis and treatment across all of rheumatology, with a special interest in gout and psoriatic arthritis.

Written by Dr. Julia Buchfuhrer, DO, rheumatologist Last updated Sources cited Editorial policy
Rheumatoid arthritisPsoriatic arthritisSpondyloarthritis

Inflammatory arthritis

Diagnosis and long-term treatment of arthritis driven by the immune system. Psoriatic arthritis plans cover every active area, from joints to skin and nails.[4]

  • Early arthritis evaluation
  • Rheumatoid arthritis
  • Psoriatic arthritis (a special interest)
  • Axial spondyloarthritis and ankylosing spondylitis
  • Treat-to-target follow-up with disease activity scores
  • Biologic and targeted oral therapy management
Request an appointment

Lungs and joints, under one roof

Some rheumatic diseases, such as rheumatoid arthritis, scleroderma and myositis, can affect the lungs, for example as interstitial lung disease. The office is shared with Dr. Mark J. Buchfuhrer, a pulmonary and sleep medicine specialist, which makes it easier to coordinate care when both are needed.

Spanish-speaking patients

Visits can be held fully in Spanish, from your history to your treatment plan. Se habla español. Atendemos a pacientes en inglés y en español.

Treatments and procedures in detail

Who each one is for, what actually happens, and what's useful to know before you start.

New-patient rheumatology evaluation

Who it's for
Anyone with joint pain and swelling, long morning stiffness, unexplained rashes or fevers, or abnormal autoimmune blood tests.
What happens
A detailed history, a head-to-toe joint, skin and nail exam, and a review of earlier labs and imaging. New blood tests or imaging are ordered only when they will change the plan.
Good to know
You leave with a working diagnosis or a clear list of what still needs to be checked.

Joint aspiration and fluid analysis

Who it's for
A swollen joint where the cause is not yet clear, especially a suspected gout or pseudogout flare.
What happens
A thin needle removes a small amount of fluid from the joint. The fluid is checked for crystals, infection and signs of inflammation.
Good to know
Finding crystals under the microscope is the most reliable way to confirm gout or pseudogout.

Joint and soft-tissue injections

Who it's for
Flares of osteoarthritis, gout or inflammatory arthritis in one or a few joints, and some tendon and bursa problems.
What happens
A corticosteroid is injected into the joint or soft tissue, sometimes after removing fluid. The visit is short, and most people walk out normally.
Good to know
The ACR/Arthritis Foundation guideline recommends steroid injections for knee and hip osteoarthritis as one part of treatment.[3]

Disease-modifying and biologic therapy

Who it's for
People with rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, lupus and other autoimmune conditions.
What happens
Choosing a medicine that calms the immune system, such as methotrexate, hydroxychloroquine, a biologic or a targeted oral drug, and adjusting it until the disease is controlled.
Good to know
Many plans follow a treat-to-target approach: agree on a goal, check progress at each visit, and adjust until you reach it.

Gout treat-to-target program

Who it's for
Anyone with repeated gout flares, tophi (chalky deposits) or joint damage on X-ray.
What happens
Starting urate-lowering medicine at a low dose, raising it step by step, and checking uric acid until it stays below 6 mg/dL. Flare-prevention medicine is used during the first months.
Good to know
This is how the 2020 ACR gout guideline recommends managing gout long-term.[2]

Positive ANA and autoimmune work-up

Who it's for
People told they have a positive ANA, or who have symptoms such as rashes, mouth sores, dry eyes, Raynaud's or unexplained fevers.
What happens
Matching the ANA result with symptoms, exam findings and more specific antibody tests, plus urine and blood counts when lupus is a question.
Good to know
Many people with a positive ANA do not have an autoimmune disease. A careful work-up gives a clear answer.

Medication safety monitoring

Who it's for
Anyone on long-term medicines such as methotrexate, leflunomide, biologics or hydroxychloroquine.
What happens
Scheduled blood tests for blood counts, liver and kidney function, plus reminders about vaccines and eye screening where relevant.
Good to know
Your lab schedule is written into your plan so nothing gets missed.

Bone health evaluation

Who it's for
People on long-term steroids, and others at higher risk for osteoporosis.
What happens
Reviewing fracture risk, bone density results, vitamin D and calcium intake, and treatment options when bone strength is low.
Good to know
Steroids used for rheumatic disease can thin bones, so bone health is part of a full rheumatology plan.

Availability of specific in-office procedures can vary. Email the office to confirm what's right for you.

How rheumatoid arthritis treatment is usually stepped

A simplified view of the 2021 American College of Rheumatology guideline. Your plan may differ based on your health and preferences.

  1. Confirm the diagnosis

    Exam, blood tests (rheumatoid factor, anti-CCP, ESR, CRP) and X-rays or ultrasound when needed.

  2. Start methotrexate

    For moderate to high disease activity in people new to treatment, methotrexate on its own is the strongly recommended first choice.

  3. Check against a target

    Disease activity is measured at follow-up visits, aiming for remission or low disease activity.

  4. Add or switch

    If the target isn't reached, a biologic or targeted oral medicine is added or swapped in.

  5. Keep steroids short

    Long-term glucocorticoids are avoided where possible because of their side effects.

Source: ACR 2021 rheumatoid arthritis guideline.[1]

Sources and references

  1. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924-939. View source
  2. FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Rheumatol. 2020;72(6):879-895. View source
  3. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162. View source
  4. Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nat Rev Rheumatol. 2022;18(8):465-479. View source
  5. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73(8):1349-1365. View source

Let's get you moving again.

New patients are welcome. Send a request and the team will get back to you to confirm a time. Se habla español.